FilingSEC EDGAR6-K
PolyPid Receives EMA Validation for D-PLEX100 Marketing Authorization Application
· SEC accepted
StageRegulatory Review
Filing content
The European Medicines Agency has validated the Marketing Authorization Application for D-PLEX100 and initiated a formal review.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…